Our Funds
Seed Fund I
Established a portfolio of early stage medical device companies that looked to solve real problems.
Seed Fund II
Created investment opportunities that allowed direct engagement into company operations.
Accellerator
Continued investing in technologies that improve outcomes & reduce healthcare system costs.
Opportunity
The Opportunity Fund leverages the foundation that the cultivate(MD) Seed and Accelerator Funds have built since 2017.
Representative Investments
Embody
Embody, Inc., is a regenerative medicine company focused on the development and commercialization of implantable medical devices to address the unmet demands in soft tissue restoration and regeneration.
Imascap
Imascap develops software for preoperative planning of shoulder replacement surgery.
Shoulder Innovations
Shoulder Innovations’ InSet™ Total Shoulder Replacement System addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant.
News and Updates
Virtual Incision Extends Series C Round with Additional $30M Funding
LINCOLN, Neb.–(BUSINESS WIRE)– Virtual Incision Corporation, the developer of the world’s first miniaturized robotic-assisted surgery (RAS) system, announced a $30 million extension to its previous
Shoulder Innovations Announces Securing of a $45M Debt Facility
Grand Rapids, Mich., August 22nd, 2023 — Shoulder Innovations Inc. (SI), a Grand Rapids, Michigan-based leader in the shoulder replacement implant market, announced securing of a $45M
HAPPE Spine Announces First Clinical Use of the INTEGRATE®-C Interbody Fusion System
Grand Rapids, Mich., August 14, 2023—HAPPE Spine announces that the first clinical case with the INTEGRATE®-C Interbody Fusion System was completed by co-inventor and neurosurgeon
cultivate (MD) Capital Funds Portfolio Company Virtual Incision Submits FDA De Novo Request for Market Authorization of MIRA
Grand Rapids, Mich., May 22, 2023— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today
HAPPE Spine Announces FDA Clearance for the INTEGRATE-C™ Interbody Fusion System
Grand Rapids, Mich., May 8, 2023 — HAPPE Spine, a medical device company focused on bringing innovative materials to orthopaedic implants, announces that the company’s
Shoulder Innovations Announces Additional Patent for Inset™ Reverse Shoulder System
Grand Rapids, Mich., April 27th, 2023 Shoulder Innovations Inc. (SI), a Grand Rapids, Michigan based leader in the shoulder replacement implant market, announced today that